Jun 25 |
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
|
May 22 |
T2 Biosystems regains compliance with Nasdaq rule on market value of listed securities
|
May 22 |
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
|
May 17 |
T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|
May 15 |
Sector Update: Health Care Stocks Advance Late Wednesday Afternoon
|
May 15 |
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|
May 14 |
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
|
May 7 |
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
|
May 7 |
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
|
May 7 |
Q1 2024 T2 Biosystems Inc Earnings Call
|